Skip to content

Inspection Record

Protein Sciences Corporation — FDA 483 Findings

US FDAInspected 2026-03-17Published 2026-10-26 6 findingsEquipment and facilityContamination controlComputer system validationMaterial and supplier controlQuality unit oversight

Inspectors Christian Lynch · Richard L Bartlett · Matthew J GretkierewiczThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Equipment and Facilities are not designed to prevent the potential for contamination.

2Contamination control

Written procedures designed to prevent microbiological contamination of drug substance are not established or are not followed.

3Computer system validation

Computerized systems used for the collection and analysis of quality data have not been validated.

4Material and supplier control

Inadequate controls for inventory of critical starting materials in (6b)(4) used in the manufacture of Flublok Monovalent Drug Substance, which is used to manufacture Flublok recombinant influenza vaccine.

5Equipment and facility

Flow of materials and equipment is not designed to prevent contamination.

6Quality unit oversight

The Quality Unit has failed to provide adequate oversight and ensure the implementation of effective corrective and preventive actions.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Protein Sciences Corporation company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.